PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsAlexza Pharmaceuticals
Alexza Pharmaceuticals(ALXA)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
AdasuveLoxapine2012-12-212024-2026
Schizophrenia
,
Psychotic disorders
,
Bipolar disorder
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Loxapine
psychomotor agitation
Benzodiazepine
healthy volunteers/patients
,
neoplasms
,
muscular atrophy
,
spinal muscular atrophy
,
hepatitis b
,
chronic hepatitis b
,
hepatitis
,
hepatitis a
,
developmental disabilities
,
mental disorders
,
neurodevelopmental disorders
,
autistic disorder
,
autism spectrum disorder
,
pervasive child development disorders
,
drug misuse
,
schizophrenia
,
breast neoplasms
,
anxiety disorders
,
generalized anxiety disorder
Tozadenant
hepatitis c
,
chronic hepatitis c
,
chronic hepatitis b
Antineoplaston a10
adenoviridae infections
Histone-arginine methyltransferase carm1
healthy volunteers/patients
,
small cell lung carcinoma
,
obesity
,
overweight
,
psoriasis
,
urologic neoplasms
,
carcinoma
,
non-small-cell lung carcinoma
,
head and neck neoplasms
,
brain neoplasms
,
breast neoplasms
,
lung neoplasms
,
systemic lupus erythematosus
,
type 2 diabetes mellitus
,
diabetes mellitus
,
covid-19
,
kidney diseases
,
polycystic kidney diseases
,
asthma
Trinessa
healthy volunteers/patients
,
hiv infections
,
hepatitis c
,
acquired immunodeficiency syndrome
,
hepacivirus
,
chronic hepatitis c
,
systemic lupus erythematosus
,
alzheimer disease
Surlorian
hepatitis b
,
chronic hepatitis b
,
hepatitis
,
hepatitis a
,
virus diseases
,
herpesviridae infections
,
adenocarcinoma of lung
,
hepatitis c
,
ebola hemorrhagic fever
,
atopic dermatitis
,
eczema
,
dermatitis
,
cardiovascular diseases
,
coronary artery disease
,
respiratory tract diseases
,
major depressive disorder
,
pulmonary tuberculosis
,
multidrug-resistant tuberculosis
,
psoriatic arthritis
,
venous thromboembolism
,
human influenza
,
thromboembolism
,
venous thrombosis
,
pulmonary embolism
,
prostatic neoplasms
,
leukemia
,
myeloid leukemia acute
,
myeloid leukemia
,
thrombosis
,
prostatectomy
,
neonatal alloimmune thrombocytopenia
,
myasthenia gravis
,
psoriasis
,
lupus nephritis
,
nephritis
Fluoroquinolone
healthy volunteers/patients
,
diabetes mellitus
,
pharmacokinetics
,
major depressive disorder
,
neoplasms
,
long qt syndrome
,
alzheimer disease
,
asthma
,
chronic obstructive pulmonary disease
,
lung diseases
,
respiration disorders
,
emphysema
,
bronchiolitis
,
rheumatoid arthritis
,
non-alcoholic fatty liver disease
,
alcoholic fatty liver
,
sepsis
,
septic shock
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use